Why the study?
Does lipid emulsion therapy improve resuscitation outcomes in patients with local anesthetic cardiotoxicity?
Does lipid emulsion therapy improve resuscitation outcomes in patients with local anesthetic cardiotoxicity?
Lipid emulsion therapy is recommended to be available in all locations performing regional anesthesia to treat rare but catastrophic local anesthetic cardiotoxicity.
Answers are grounded in this paper and cite their sources.
Supports lipid emulsion availability for regional anesthesia; leaves open need for randomized confirmation in LAST.
Cardiovascular collapse from accidental local anesthetic toxicity is a rare but catastrophic complication of regional anesthesia. The long-acting amide local anesthetics bupivacaine, levobupivacaine and ropivacaine have differential cardiac toxicity, but all are capable of causing death with accidental overdose. In recent times, the chance discovery that lipid emulsion may improve the chance of successful resuscitation has lead to recommendations that it should be available in every location where regional anesthesia is performed. This review will outline the mechanisms of local anesthetic toxicity and the rationale for lipid emulsion therapy.
No takes yet. Share an insight, caveat, or question.
A 2010 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: